# Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy

> **NCT00962429** · PHASE2 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 7 (actual)

## Conditions studied

- CIDP
- Chronic Inflammatory Demyelinating Polyneuropathy

## Interventions

- **DRUG:** lipoic acid

## Key facts

- **NCT ID:** NCT00962429
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2020-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00962429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00962429, "Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00962429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*